Methylprednisolone Recruiting Phase 2 Trials for Acute Lung Injury (ALI) / Acute Respiratory Distress Syndrome (ARDS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01757899Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children